Li Y, Liu Z, Qian Y, Wang K, et al. Ultrasounic-radiomics models for predicting the response to Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma. PLoS One 2025;20:e0334099.
PMID: 41160615